Trial Profile
Clinical Trials Insight: 700052542
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2010
Price :
$35
*
At a glance
- Drugs Hepatitis C vaccine (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Compass Biotechnologies
- 13 Jan 2010 New trial record